申请人:Merck & Co., Inc.
公开号:US04092414A1
公开(公告)日:1978-05-30
3,4-Dihydrospiro-2H-1,3-benzoxazines are prepared by condensing aminomethylphenols with cyclic ketones. The products are diuretic and anti-inflammatory agents, and are useful in the treatment of autoimmune diseases, such as multiple sclerosis.
3,4-二氢螺-2H-1,3-苯并噁嗪是通过将氨甲基酚与环状酮缩合制备的。该产品是利尿剂和抗炎剂,并可用于治疗自身免疫性疾病,如多发性硬化症。